Parallel trade in North America
by Decision Resources Inc.
This white paper by Decision Resources Inc. describes the affordability of prescription drugs in the United States, a subject of intense debate among government, the pharmaceutical industry, consumer advocates, health insurers and other stakeholders. It explains the potential for parallel trade between Canada and the U.S. and the implications for the pharmaceutical industries of both countries. The white paper assesses the impact of the growing number of Canadian internet pharmacies that sell to U.S. customers, and reviews the responses of drug manufacturers and others; parallel trade in products that are still patent-protected in the United States would raise important and highly controversial intellectual property issues. According to this white paper, most products are sold under the same name in both countries to maximize brand equity. It outlines entire process from submission of the prescription to delivery of the medicines in Canada and the United States.
| Published: | 2003 |
| Format: | |
| Length: | 14 Pages |
| Type: | White paper |
| Language: | English |
.
SPONSORED REPORTS
